These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15368928)

  • 1. [Present treatment of Guillain-Barre syndrome].
    Raphaël JC
    Bull Acad Natl Med; 2004; 188(1):87-94; discussion 94-5. PubMed ID: 15368928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Guillain-Barré syndrome].
    Raphaël JC
    Rev Prat; 2005 Apr; 55(8):823-7. PubMed ID: 15999835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guillain-Barré syndrome: epidemiological, clinical and therapeutic insight].
    Raphaël JC; Sharshar T
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S35-40. PubMed ID: 10896987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guillain-Barré syndrome in the adult: therapeutic aspects].
    Raphael JC; Cardinaud JP; Fourrier F; Guidet B; Perrotin D
    Schweiz Med Wochenschr; 1998 Sep; 128(39):1453-61. PubMed ID: 9793164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of Guillain-Barré syndrome with high-dose intravenous immunoglobulins--a comparison with plasma exchange].
    Kamei T; Nakagawa H; Uchiyama F; Fukuyama J
    Rinsho Shinkeigaku; 1993 Jun; 33(6):660-2. PubMed ID: 8403689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trial.
    Korinthenberg R; Schessl J; Kirschner J; Mönting JS
    Pediatrics; 2005 Jul; 116(1):8-14. PubMed ID: 15995024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immune globulin in the Guillain-Barré syndrome.
    van der Meché FG
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):43-7. PubMed ID: 8033434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Lancet; 1997 Jan; 349(9047):225-30. PubMed ID: 9014908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Raphaël JC; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2001; (2):CD002063. PubMed ID: 11406030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
    Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barré syndrome: critical reassessment of effectiveness and cost-efficiency.
    Oczko-Walker M; Manousakis G; Wang S; Malter JS; Waclawik AJ
    J Clin Neuromuscul Dis; 2010 Dec; 12(2):55-61. PubMed ID: 21386771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for Guillain-Barré syndrome in the US hospitals.
    Alshekhlee A; Hussain Z; Sultan B; Katirji B
    J Clin Neuromuscul Dis; 2008 Sep; 10(1):4-10. PubMed ID: 18772694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome.
    Kuitwaard K; de Gelder J; Tio-Gillen AP; Hop WC; van Gelder T; van Toorenenbergen AW; van Doorn PA; Jacobs BC
    Ann Neurol; 2009 Nov; 66(5):597-603. PubMed ID: 19938102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appropriate number of plasma exchanges in Guillain-Barré syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome.
    Ann Neurol; 1997 Mar; 41(3):298-306. PubMed ID: 9066350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Guillain-Barré syndrome and CIDP.
    van Doorn PA
    J Peripher Nerv Syst; 2005 Jun; 10(2):113-27. PubMed ID: 15958124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmapheresis treatment in Guillain-Barré syndrome: potential benefit over IVIg in patients with axonal involvement.
    Dada MA; Kaplan AA
    Ther Apher Dial; 2004 Oct; 8(5):409-12. PubMed ID: 15663537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of Guillain-Barré syndrome by plasma exchange: proposal of a therapeutic strategy].
    Raphael JC; Chevret S; Jars-Guincestre MC; Chastang C; Gajdos P
    Rev Neurol (Paris); 1996 May; 152(5):359-64. PubMed ID: 8881430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of the adult Guillain-Barré syndrome: indications for plasma exchange.
    Raphael JC; Chevret S; Auriant I; Sharshar T; Bouget J; Bolgert F
    Transfus Sci; 1999 Feb; 20(1):53-61. PubMed ID: 10621561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomics of therapy for Guillain-Barré syndrome: plasma exchange and intravenous immunoglobulin.
    Tsai CP; Wang KC; Liu CY; Sheng WY; Lee TC
    J Clin Neurosci; 2007 Jul; 14(7):625-9. PubMed ID: 17532498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanical ventilation in Guillain-Barré syndrome: does age influence functional outcome?
    Köhrmann M; Huttner HB; Nowe T; Schellinger PD; Schwab S
    Eur Neurol; 2009; 61(6):358-63. PubMed ID: 19365128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.